Recruiting

Patellar LIFT

Sponsor:

ZKR Orthopedics Inc

Code:

NCT06423300

Conditions

Patellofemoral Osteoarthritis

Eligibility Criteria

Sex: All

Age: 22 - 65

Healthy Volunteers: Not accepted

Interventions

LIFT Implant

Tibial Tubercle Osteotomy

Study Details

Brief summary:

The PELICAN study is a prospective, non randomized, dual arm, multi-center clinical study comparing clinical outcomes of subjects treated with the LIFT Implant System to subjects treated with Tibial Tubercle Osteotomy (TTO).

Conditions

Patellofemoral Osteoarthritis

Study ID

NCT06423300

Start date

Jun 19, 2024

Status verified date

Dec, 2025

Completion date

Sep, 2031

Anticipated

Primary completion date

Sep, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 22 - 65

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Patients age 22 to 65 years at time of screening
2. Anterior knee pain due to patellofemoral cartilage degeneration (PCD) with an Modified Outerbridge score of ≥3 as assessed by an MRI on the study knee
3. Body Mass Index (BMI) of ≤ 35
4. Weight < 300 lbs
5. Anterior Knee Pain Score (AKPS) of ≤ 70 (0-100 scale)
6. Visual Analog Score (VAS) of ≥ 40 (0-100 scale)
7. Failure of at least 6 months of non-surgical treatment defined as at least one of the treatments (e.g. rest, bracing, physical therapy, targeted exercise, use of NSAIDs, activity level reduction or Confidential ZKR Orthopedics, CIP 0001 Page 11 of 55 Protocol Version: 1.0, 04JAN2024 modification, etc.) per AAOS Treatment of Osteoarthritis of the Knee; Evidence based guideline 3rd Edition 2021

Exclusion Criteria:

1. PCD with an Modified Outerbridge Score of 2 or less at the study knee
2. Clinical symptoms of the contralateral knee that preclude activities of daily living, stair climbing, stair descending, or require the use of an assist device
3. History of patella dislocation or instability
4. Patella alta or patella baja
5. Known TT-TG distance >20mm
6. Patients requiring simultaneous cartilage grafting procedure, cartilage transplantation, or bone marrow stimulation
7. Previous repair of a torn patellar tendon
8. Prior TTO procedure or knee joint replacement (total or partial) of the study knee
9. Joint modifying surgery (e.g., ligament reconstruction, meniscus repair, cartilage transplantation, microfracture, etc.) in the study knee within 6 months prior to planned index procedure date
10. Arthroscopic surgeries in the study knee for joint lavage, meniscectomy, chondral debridement, and loose body removal within 3 months prior to planned index procedure
11. Active infection, sepsis, osteomyelitis or history of septic arthritis in any joint
12. Rheumatoid arthritis, other forms of inflammatory joint disease or autoimmune disorder
13. History of avascular necrosis of any bone
14. History of symptomatic patellar tendonitis of intrasubstance tear
15. Insufficiency of the cruciate, collateral ligaments, or tendon which would preclude stability of the LIFT System
16. Pathologic ligamentous injury (Lachman > 1) or meniscus tearing
17. Clinical symptoms of the femoral-tibial joint of the study knee that preclude activities of daily living, stair climbing, stair descending, or requires the use of an assist device
18. Evidence (MRI, arthroscopy, etc.) of Modified Outerbridge Grade 4 degenerative arthritis in the femoral-tibial joint of the study knee that potentially explains patient symptoms

Study Design

Enrollment

245 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Treatment Group: LIFT

Subjects receiving the LIFT implant system.

active comparator: Control Group: TTO

Subjects receiving a Tibial Tubercle Osteotomy (TTO)

Interventions

LIFT Implant

The LIFT implant provides a less invasive option for treatment of patellofemoral cartilage degeneration in the knee. the LIFT implant unloads the patellofemoral joint by elevating the patellar tendon to unload the joint compartment and realign the kneecap toward healthier cartilage

Tibial Tubercle Osteotomy

Tibial Tubercle Osteotomy

Primary outcome measure

  • 24 month composite endpoint demonstrating non-inferiority of the LIFT System as compared to TTO. [ Time Frame: 24 months ]

Central Contacts and Locations

Locations

Horizon Clinical Research

Recruiting

La Mesa, California, United States, 91942

Contacts

Principal Investigator:

Scott Hacker, MD

Hospital for Special Surgery

Recruiting

New York, New York, United States, 10021

Contacts

Hannah Terry

terryh@hss.edu

Principal Investigator:

Sabrina Strickland, MD

NYU Langone Health

Recruiting

New York, New York, United States, 11220

Contacts

Principal Investigator:

Alexander Golant, MD

Ohio State University - Jameson Crane Sports Medicine Institute

Recruiting

Columbus, Ohio, United States, 43202

Contacts

Principal Investigator:

David Flanigan, MD

Oregon Health and Science University

Recruiting

Portland, Oregon, United States, 97239

Contacts

Jessica Ballin

ballin@ohsu.edu

Principal Investigator:

Dennis Crawford, MD

More Information

Sponsor

ZKR Orthopedics Inc

Last update posted

Dec 11, 2025

Last verified

Dec, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by ZKR Orthopedics Inc on 2025-12-11.